Fertility and Age: What the Science Actually Says About Your Reproductive Window
The science of fertility and age is real — but often distorted. Understanding what actually happens to ovarian reserve, egg quality, and miscarriage risk by decade gives women the information they need to make genuinely informed decisions.

Fertility declines with age. This is physiologically true, clinically important, and also one of the most anxiety-provoking messages my patients carry into their appointments — often shaped more by alarmist headlines than by the actual science. The reality is more nuanced: decline is gradual through the late twenties and early thirties, meaningfully accelerates after 35, and becomes clinically significant after 37 to 38. Most women in their early thirties who want to conceive will do so. The conversation deserves precision, not panic, and it deserves to start earlier than most women are currently having it — ideally at an annual gynecological visit in the late twenties, well before conception is being actively planned.
How Ovarian Reserve Works
Women are born with all the eggs they will ever have — roughly one to two million primordial follicles at birth, which are not replenished. By puberty, this number has naturally declined to approximately 300,000 to 500,000. Over the course of a woman's reproductive life, roughly 400 to 500 eggs are recruited to ovulation; the vast majority are lost through atresia (a process of natural follicle death unrelated to ovulation). By the time a woman reaches her late thirties, the remaining pool has both declined in number and — critically — declined in egg quality, as the oocytes that remain have been sitting in a state of arrested cell division for decades, accumulating chromosomal damage.
The ovarian reserve, then, is both a quantity and a quality concept. Tests of ovarian reserve measure quantity reasonably well. Quality is harder to measure directly and is primarily inferred from age and from the outcomes of IVF cycles.
Tests That Predict Ovarian Reserve
Anti-Müllerian Hormone (AMH)
AMH is the most clinically useful blood test for estimating ovarian reserve. It is secreted by granulosa cells of small antral and preantral follicles and reflects the size of the remaining follicle pool. AMH levels correlate with the likely response to ovarian stimulation for IVF and provide a rough estimate of remaining reproductive lifespan. Normal AMH reference ranges by age are approximately:
- Age 25: 3.0–6.8 ng/mL (median ~4.0)
- Age 30: 2.2–5.0 ng/mL (median ~3.0)
- Age 35: 1.0–3.5 ng/mL (median ~2.0)
- Age 40: 0.5–1.8 ng/mL (median ~0.9)
- Age 45: often <0.5 ng/mL
An AMH below 1.0 ng/mL at any age is considered low and associated with reduced response to ovarian stimulation. An AMH below 0.5 ng/mL is very low and should prompt prompt consultation about fertility preservation or assisted reproduction if conception is desired. Critically, AMH does not predict whether natural conception is possible in any individual cycle — it is a population-level predictor of IVF response, not a fertility sentence. Women with low AMH can and do conceive naturally.
Antral Follicle Count (AFC)
The antral follicle count is performed via transvaginal ultrasound, typically on day two to five of the menstrual cycle, and counts the number of small (2–10 mm) resting follicles visible in both ovaries. An AFC of 10 to 20 is normal. An AFC below 6 to 7 is considered low and consistent with diminished ovarian reserve. AFC and AMH correlate closely and together provide a more complete picture than either alone.
Day 3 FSH
Follicle-stimulating hormone measured on day two or three of the menstrual cycle reflects how hard the pituitary is working to recruit follicles. As ovarian reserve declines, the pituitary must secrete more FSH to achieve the same effect. A day 3 FSH above 10 IU/L suggests diminished reserve; above 15 to 20 IU/L indicates severely diminished reserve. FSH is more variable cycle-to-cycle than AMH and is considered a less reliable standalone marker.
Fertility by Decade
JourneyDoctors
Not sure if this applies to you?
Describe your symptoms to Dr. Maya — our AI GP — and get a real clinical response in under a minute. Free to start.
Talk to Dr. MayaTwenties
Fertility is generally at its peak in the mid-to-late twenties. Monthly fecundity rate (chance of conception per cycle without contraception) is approximately 20 to 25 percent. Miscarriage risk is roughly 10 to 12 percent per recognized pregnancy. Egg quality at this age is the highest it will be. Women in their twenties who are not yet planning pregnancy but know they want children in the future are, statistically, in the best window for egg freezing — though many will not have had this conversation with a physician.
Thirties (Early)
The early to mid-thirties (ages 30 to 35) remain a highly fertile period for most women. Monthly fecundity rates begin declining modestly, with cumulative conception rates in 12 months remaining above 80 percent in most studies of women without underlying fertility issues. Miscarriage rates are approximately 13 to 16 percent. AMH is declining but remains in ranges that support both natural conception and good IVF response. This is often the period during which women first begin having these conversations, which is reasonable — but earlier is better for those with family history of premature ovarian insufficiency or other risk factors.
Thirty-Five to Thirty-Eight: The Inflection Point
Age 35 is not a cliff — it is a statistical marker, chosen partly because clinical studies used it as a cutoff and it became embedded in medical discourse as the age at which pregnancy becomes "advanced maternal age" (AMA). What is actually happening around 35 to 38 is a meaningful acceleration of egg quality decline. The rate of chromosomally abnormal eggs (aneuploidy) increases significantly: approximately 20 to 25 percent of eggs are aneuploid at age 30, rising to 40 to 50 percent by 37 to 38, and exceeding 70 percent by the early forties. Aneuploid embryos are the primary cause of both implantation failure and first-trimester miscarriage. This is why miscarriage risk climbs steeply after 37: approximately 25 to 30 percent by age 40, and 40 to 50 percent or more by the mid-forties.
Forties
Natural conception remains possible in the early forties — roughly 5 percent of women will conceive naturally in a given month at age 40, declining to about 1 to 2 percent by 43 to 44. The clinical picture shifts significantly: time to conception lengthens, miscarriage rates climb, and IVF success rates with a woman's own eggs drop substantially. Live birth rate per IVF cycle using own eggs is approximately 20 to 25 percent at age 40, 10 to 15 percent at 42, and below 5 percent by 45. IVF with preimplantation genetic testing (PGT-A) can improve the probability of live birth per transfer by selecting chromosomally normal embryos but cannot create normal embryos where none exist — it can only find them if they are there.
Egg Quality vs Egg Quantity
Ovarian reserve tests measure quantity. They do not directly measure quality — and quality is the more clinically significant variable for conception outcomes, particularly after 37. A woman can have a high AMH (large follicle pool) but produce a high proportion of aneuploid eggs due to age alone. Conversely, a woman with low AMH may still produce high-quality eggs if she is young. This is why age remains the single most important predictor of egg quality and IVF success, even after adjusting for AMH and AFC.
Fertility Preservation: Egg Freezing
Oocyte cryopreservation (egg freezing) using vitrification technology has become a viable fertility preservation strategy. The American Society for Reproductive Medicine (ASRM) no longer considers egg freezing experimental as of 2012. Key considerations:
- The number of mature eggs retrieved per cycle is the most important variable: most reproductive endocrinologists recommend a target of 15 to 20 mature eggs for reasonable odds of at least one live birth when ready to use them.
- Younger eggs are higher quality eggs: egg freezing at 32 produces better outcomes than at 38, using the same technology. The biology of the eggs at the time of freezing is fixed.
- Live birth rates per frozen egg are approximately 2 to 12 percent per egg at ages under 35, lower at older ages.
- Most patients require one to three stimulation cycles to bank an adequate number of eggs.
- Cost is a significant barrier: stimulation and retrieval typically costs $10,000 to $15,000 per cycle in the US, plus annual storage fees. A small but growing number of employers cover egg freezing as a benefit.
Donor Eggs
For women with severely diminished ovarian reserve, premature ovarian insufficiency, or age-related egg quality decline, donor egg IVF offers the highest live birth rates of any fertility treatment — typically 50 to 60 percent per transfer when using eggs from young, screened donors. The uterine environment of a woman in her forties or even early fifties is generally capable of supporting a healthy pregnancy; it is egg quality, not uterine aging, that is the primary limiting factor. Donor egg IVF requires psychological preparation and is a profoundly personal decision, but it is an effective option that many women wish they had considered earlier in their fertility journey.
Male Factor Fertility and Age
Male fertility also declines with age, though more gradually. After age 40 to 45, sperm parameters begin to deteriorate measurably: DNA fragmentation increases, motility declines, and morphology worsens. Paternal age above 40 is associated with modest increases in miscarriage risk and a small but real increase in risk of certain conditions including autism spectrum disorder and schizophrenia in offspring. However, men's age-related fertility decline is substantially slower and less clinically limiting than women's, and natural conception with healthy sperm is possible well into the fifties and beyond for many men.
What Actually Predicts Fertility Beyond Age
Age is the dominant predictor, but it is not the only one. Conditions that can profoundly affect fertility regardless of age include: polycystic ovary syndrome (PCOS), which causes ovulatory dysfunction; endometriosis, which affects both egg quality and the uterine environment; fibroids, particularly submucosal fibroids that distort the uterine cavity; pelvic inflammatory disease and tubal factor infertility from prior STIs; thyroid dysfunction (both hypo- and hyperthyroidism suppress ovulation); BMI extremes (both low body weight and obesity impair ovulatory function); prior chemotherapy or pelvic radiation; and genetic conditions such as fragile X premutation carriers, who are at high risk for premature ovarian insufficiency.
When to See a Doctor
Couples under 35 who have been trying to conceive for twelve months without success should seek fertility evaluation. Women 35 and older should seek evaluation after six months. Women 40 and older should consider consulting a reproductive endocrinologist proactively after three months of trying, given the time-sensitive nature of fertility at this age. Any woman with irregular periods, known endometriosis, prior pelvic infection, or family history of premature menopause should not wait. JourneyDoctors connects you with trained specialists from $19. Start a consultation today — no waiting room, no referral needed.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment.
Get proper care
Ready to speak with a specialist?
If anything in this article sounds familiar, the right next step is a proper evaluation. JourneyDoctors connects you with a specialist in minutes. Consultations from $19.
See a specialist nowFrequently Asked Questions
Does a regular menstrual cycle mean I have normal fertility?
Regular cycles confirm that ovulation is occurring, which is an important component of fertility — but not the whole picture. Ovarian reserve, egg quality, uterine anatomy, tubal patency, and male factor are all separate variables. A woman with regular cycles can still have diminished ovarian reserve, endometriosis, a tubal blockage from prior infection, or a structural uterine abnormality. Regular cycles are reassuring but not a fertility guarantee.
What is the best age to freeze eggs?
From a purely biological standpoint, the earlier the better — eggs frozen in the late twenties are higher quality than eggs frozen in the late thirties. However, most fertility specialists consider the late twenties to early thirties to be the practical sweet spot: eggs are still high quality, but women have enough life perspective to make an informed decision about whether fertility preservation aligns with their plans. Egg freezing after 38 is less effective per cycle and typically requires more cycles to bank an adequate number of eggs.
Can I get pregnant naturally at 40?
Yes, natural conception at 40 is possible. Approximately 5 percent of women 40 to 41 conceive naturally in any given month, and many women in their early forties achieve pregnancies with or without assistance. The risks of miscarriage (roughly 25 to 40 percent) and chromosomal abnormalities increase substantially, which is why prenatal genetic testing (cell-free DNA screening, amniocentesis) is recommended for all pregnancies in women 35 and older. Natural conception without assistance at 43 or 44 is considerably less common but not impossible.
Does birth control use affect future fertility?
Long-term use of hormonal contraceptives does not impair future fertility. After stopping combined oral contraceptives, normal ovulatory cycling resumes within one to three months for most women. A temporary delay of one to two cycles is common. There is no evidence that years of contraceptive use deplete ovarian reserve or reduce the chance of future pregnancy. The age at which a woman chooses to start trying is far more important than whether she used contraception beforehand.
What is premature ovarian insufficiency?
Premature ovarian insufficiency (POI), formerly called premature menopause, is diagnosed when ovarian function declines before age 40, causing irregular or absent periods, elevated FSH, low estrogen, and potential fertility loss. It affects approximately 1 percent of women under 40 and up to 0.1 percent under 30. Causes include genetic factors (fragile X premutation, Turner syndrome variants), autoimmune destruction of ovarian tissue, and prior chemotherapy or radiation. Women with a family history of POI should seek earlier fertility evaluation and counseling.
Written by
Dr. Fatima Al-Rashid
OB-GYN

